Sorrento Therapeutics Investor
Clinical and commercial stage biopharmaceutical companySorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, develops a portfolio of next-generation treatments for three therapeutic areas: cancer, infectious disease,and pain. It operates through two segments, Sorrento Therapeutics and : OTCMKTSFiscal Year: January-DecemberReporting Currency: USDTicker Symbol: SRNESorrento Therapeutics Company Description - Stock /?
Headquarters:
United States, Pl, San Diego
Founded Date:
1989.0
Number Of Exists:
N/A
Employee Number:
5
Investor Type:
Private Equity Firms